Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic

dc.contributor.authorSingh, Pen_US
dc.contributor.authorKumar, Aen_US
dc.date.accessioned2020-04-10T02:06:00Z
dc.date.available2020-04-10T02:06:00Z
dc.date.issued2020-01
dc.description.abstractPatients with moderate to severe dry eyes are often screened at the Dry Eye Clinic to rule out connective tissue diseases. Rheumatoid factor (RF) is one of the screening tools to rule out rheumatoid arthritis (RA). Patients who turn out positive for the RF are often subjected to anti-CCP antibody evaluation for confirmation of disease. This article tries to highlight 3 cases of negative and anti-CCP antibody positive cases which presented to the ophthalmic clinic, unaware of their systemic status. Though RF is the cheapest modality to screen for RA, it is not always a reliable marker. One should order anti-CCP antibody for patients where suspicion is high, despite RF being normal.en_US
dc.identifier.affiliationsHead of Cornea and Anterior Segment Services, Nirwana Netralaya, Sasaram, Rohtas, Bihar, Indiaen_US
dc.identifier.affiliationsHead of Occuloplasty Services, Nirwana Netralaya, Sasaram, Rohtas, Bihar, Indiaen_US
dc.identifier.affiliationsNirwana Netralaya, Sasaram, Rohtas, Bihar, Indiaen_US
dc.identifier.citationSingh P, Kumar A. Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic. Indian Journal of Ophthalmology. 2020 Jan; 68(1): 236-238en_US
dc.identifier.issn0301-4738
dc.identifier.issn1998-3689
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/197777
dc.languageenen_US
dc.publisherAll India Ophthalmological Societyen_US
dc.relation.issuenumber1en_US
dc.relation.volume68en_US
dc.source.urihttps://dx.doi.org/10.4103/ijo.IJO_526_19en_US
dc.subjectAnti-CCP antibodyen_US
dc.subjectophthalmic clinicen_US
dc.subjectRheumatoid factoren_US
dc.titleRheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinicen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijo2020v68n1p236.pdf
Size:
1.06 MB
Format:
Adobe Portable Document Format